Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Norio Harada"'
Autor:
Ryotaro Bouchi, Tatsuya Kondo, Yasuharu Ohta, Atsushi Goto, Daisuke Tanaka, Hiroaki Satoh, Daisuke Yabe, Rimei Nishimura, Norio Harada, Hideki Kamiya, Ryo Suzuki, Toshimasa Yamauchi, JDS Committee on Consensus Statement Development
Publikováno v:
Journal of Diabetes Investigation, Vol 15, Iss 9, Pp 1326-1342 (2024)
Externí odkaz:
https://doaj.org/article/1403c6e39c2f4815b55d482614899a80
Publikováno v:
Journal of Diabetes Investigation, Vol 15, Iss 6, Pp 704-706 (2024)
Externí odkaz:
https://doaj.org/article/a45b42f45c4a443ca21fdb8a5a98a7e3
Autor:
Akihiro Hamasaki, Norio Harada, Atsushi Muraoka, Shunsuke Yamane, Erina Joo, Kazuyo Suzuki, Nobuya Inagaki
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
IntroductionIncretin-based drugs are extensively utilized in the treatment of type 2 diabetes (T2D), with remarkable clinical efficacy. These drugs were developed based on findings that the incretin effect is reduced in T2D. The incretin effect in Ea
Externí odkaz:
https://doaj.org/article/8161b599d06c43c2847ed02fe5a9a957
Autor:
Ichiro Yamauchi, Takuro Hakata, Taku Sugawa, Daisuke Kosugi, Haruka Fujita, Kentaro Okamoto, Yohei Ueda, Toshihito Fujii, Daisuke Taura, Norio Harada, Nobuya Inagaki
Publikováno v:
Endocrine Journal, Vol 70, Iss 10, Pp 987-998 (2023)
Immune checkpoint inhibitors (ICIs) are used for various malignancies, although they frequently cause immune-related adverse events involving the thyroid gland (thyroid irAEs). We conducted a retrospective cohort study to elucidate thyroid function o
Externí odkaz:
https://doaj.org/article/5377cab0fa8d4a11b42f449e3fa68f31
Autor:
Takuma Yasuda, Norio Harada
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 11, Pp 1234-1236 (2023)
Externí odkaz:
https://doaj.org/article/764ea41c859948fbbfc62673c23881f7
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 9, Pp 1038-1040 (2023)
Externí odkaz:
https://doaj.org/article/814e1ba2245949aca8a75a3513c33648
Autor:
Masashi Hasebe, Satoshi Yoshiji, Yamato Keidai, Hiroto Minamino, Takaaki Murakami, Daisuke Tanaka, Yoshihito Fujita, Norio Harada, Akihiro Hamasaki, Nobuya Inagaki
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-16 (2023)
Abstract Background Effects of antihyperglycemic therapies on cardiovascular and heart failure (HF) risks have varied widely across cardiovascular outcome trials (CVOTs), and underlying factors remain incompletely understood. We aimed to determine th
Externí odkaz:
https://doaj.org/article/7c66de8a2c394852a861e33ded66de9e
Autor:
Ryotaro Bouchi, Tatsuya Kondo, Yasuharu Ohta, Atsushi Goto, Daisuke Tanaka, Hiroaki Satoh, Daisuke Yabe, Rimei Nishimura, Norio Harada, Hideki Kamiya, Ryo Suzuki, Toshimasa Yamauchi, JDS Committee on Consensus Statement Development
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 1, Pp 151-164 (2023)
Externí odkaz:
https://doaj.org/article/f0ffe37a51c14384bf8935165ce83352
Autor:
Tomonobu Hatoko, Norio Harada, Shinsuke Tokumoto, Shunsuke Yamane, Eri Ikeguchi-Ogura, Tomoko Kato, Takuma Yasuda, Hisato Tatsuoka, Satoko Shimazu-Kuwahara, Daisuke Yabe, Yoshitaka Hayashi, Nobuya Inagaki
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Tissue optical clearing permits detailed evaluation of organ three-dimensional (3-D) structure as well as that of individual cells by tissue staining and autofluorescence. In this study, we evaluated intestinal morphology, intestinal epithel
Externí odkaz:
https://doaj.org/article/444c2be1c89a4867a8b89ba4bb7497c6
Autor:
Alice Adriaenssens, Johannes Broichhagen, Anne de Bray, Julia Ast, Annie Hasib, Ben Jones, Alejandra Tomas, Natalie Figueredo Burgos, Orla Woodward, Jo Lewis, Elisabeth O’Flaherty, Kimberley El, Canqi Cui, Norio Harada, Nobuya Inagaki, Jonathan Campbell, Daniel Brierley, David J. Hodson, Ricardo Samms, Fiona Gribble, Frank Reimann
Publikováno v:
JCI Insight, Vol 8, Iss 10 (2023)
Central glucose-dependent insulinotropic polypeptide (GIP) receptor (GIPR) signaling is critical in GIP-based therapeutics’ ability to lower body weight, but pathways leveraged by GIPR pharmacology in the brain remain incompletely understood. We ex
Externí odkaz:
https://doaj.org/article/98622c9a195d4352900a24be2e5b4bd3